0001562180-21-000292.txt : 20210111 0001562180-21-000292.hdr.sgml : 20210111 20210111172538 ACCESSION NUMBER: 0001562180-21-000292 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210101 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alger Jason CENTRAL INDEX KEY: 0001839111 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38993 FILM NUMBER: 21521697 MAIL ADDRESS: STREET 1: C/O HEALTH CATALYST STREET 2: 3165 MILLROCK DR #400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst, Inc. CENTRAL INDEX KEY: 0001636422 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 453337483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3165 E. MILLROCK, SUITE 400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 801-708-6800 MAIL ADDRESS: STREET 1: 3165 E. MILLROCK, SUITE 400 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: HQC Holdings, Inc. DATE OF NAME CHANGE: 20150312 3 1 primarydocument.xml PRIMARY DOCUMENT X0206 3 2021-01-01 0 0001636422 Health Catalyst, Inc. HCAT 0001839111 Alger Jason C/O HEALTH CATALYST, INC. 3165 MILLROCK DRIVE, #400 SALT LAKE CITY UT 84121 false true false false Chief Accounting Officer Common Stock 7634.00 D Common Stock 3125.00 D Stock Options (Right to buy) 10.80 2027-09-27 Common Stock 8070.00 D Stock Options (Right to buy) 10.78 2028-05-03 Common Stock 2242.00 D Stock Options (Right to buy) 10.72 2027-10-26 Common Stock 5200.00 D Stock Options (Right to buy) 10.60 2026-10-14 Common Stock 832.00 D Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on December 1, 2020 and the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Includes 134 shares purchased pursuant to the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2020, which transaction is considered exempt pursuant to Rule 16b-3(c) promulgated under the Securities Exchange Act of 1934. Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on June 1, 2020 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments. 25% of the shares vested on September 25, 2019, and the remaining 75% vest in 36 equal monthly installments thereafter. 25% of the shares vested on May 3, 2019, and the remaining 75% vest in 36 equal monthly installments thereafter. 25% of the shares vested on October 26, 2018, and the remaining 75% vest in 36 equal monthly installments thereafter. 25% of the shares vested on October 14, 2017, and the remaining 75% vest in 36 equal monthly installments thereafter. /s/ Daniel Orenstein, as Attorney-in-Fact 2021-01-11